Guide to Antibody structure and isotypes | Abcam
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - 2023 - The FEBS Journal - Wiley Online Library
Immunoglobulin classes
Frontiers | High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
![Recombinant Anti-Kappa light chain antibody [EPR5367-8] (ab124727) | Abcam](https://www.abcam.com/ps/products/124/ab124727/Images/ab124727-8-anti-kappa-light-chain-antibody-epr5367-8-elisa.jpg "Recombinant Anti-Kappa light chain antibody [EPR5367-8] (ab124727) | Abcam")
Recombinant Anti-Kappa light chain antibody [EPR5367-8] (ab124727) | Abcam
Evaluation of monoclonal gammopathies - Differential diagnosis of symptoms | BMJ Best Practice US
JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
Living With - HealthTree for Multiple Myeloma
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Providence Health Care Test Catalog
Nephron Power: February 2016
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
Intrathecal kappa free light chains as markers for multiple sclerosis | Scientific Reports
Frontiers | Understanding AL amyloidosis with a little help from in vivo models
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
Sebia FLC Kappa, Serum free light chain quantification
Immunoglobulin Light Chain - an overview | ScienceDirect Topics
Medicina | Free Full-Text | The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
Validation of serum free light chain reference ranges in primary care - Luca Galvani, Jane Flanagan, Mansour Sargazi, William D Neithercut, 2016
